How does stellate ganglion block alleviate immunologically-linked disorders?
Eugene Lipov1, Vicko Gluncic1, Ivan K Lukić2
1Department of Anesthesia, Advocate Illinois Masonic Medical Center, 836 W Wellington Ave, Chicago, IL 60657, USA.
Medical Hypotheses
|August 8, 2020
Summary
Stellate ganglion block (SGB) may alleviate immune-linked disorders by modulating the immune system. This procedure impacts sympathetic innervation, potentially offering a new therapeutic avenue for conditions like ulcerative colitis.
Area of Science:
- Autonomic Nervous System
- Immunology
- Neuroscience
Background:
- The stellate ganglion, a sympathetic nervous system component, innervates the head and neck.
- Stellate ganglion block (SGB) is used for pain and vascular issues, with historical links to immune dysfunction.
- The precise mechanisms of SGB's effects on immune conditions remain poorly understood.
Purpose of the Study:
- To investigate the hypothesis that SGB modulates immune system activity by altering sympathetic innervation to immune organs.
- To elucidate the neuro-immunological pathways through which SGB may alleviate disease symptoms.
Main Methods:
- Examined sympathetic innervation of primary (thymus, bone marrow) and secondary (spleen, lymph nodes) immune organs.
- Investigated adrenergic receptor expression on lymphocytes and innate immune cells.
- Proposed a central, reflex-like pathway involving brain regions like the insula and amygdala to explain SGB's systemic effects.
Main Results:
- Sympathetic innervation and adrenergic receptors on immune cells mediate immuno-modulatory effects.
- Adrenergic signaling influences cytokine profiles (e.g., reduced pro-inflammatory, increased anti-inflammatory).
- SGB may induce beneficial immune changes, including increased regulatory T cells and a shift towards Th2 responses.
Conclusions:
- SGB shows promise in treating various conditions with measurable immunologic improvements.
- A central, reflex-like pathway regulating the immune system is a plausible mechanism for SGB's efficacy.
- This framework supports wider SGB application in immune-linked disorders, such as ulcerative colitis.
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Blockers
1.5K
Ganglionic blockers inhibit autonomic activity by blocking nicotinic receptors in the autonomic ganglia, suppressing impulse transmission. These blockers lack selectivity between sympathetic and parasympathetic ganglia and are ineffective as neuromuscular junction antagonists. They can be categorized into two groups:
1.5K
Myasthenia Gravis: Overview and Treatment
2.5K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.5K
Drugs Acting on Autonomic Ganglia: Stimulants
1.9K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.9K
T Cell Types and Functions
1.9K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.9K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.6K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.6K
Ligand-Gated Ion Channel Receptor: Gating Mechanism
3.5K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
3.5K


